• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Jumps 200 Points; Honeywell Trims Profit Outlook

    7/25/24 10:39:49 AM ET
    $EZFL
    $HON
    $KDLY
    $PBM
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary
    Aerospace
    Industrials
    Get the next $EZFL alert in real time by email

    U.S. stocks traded mixed this morning, with the Dow Jones gaining over 200 points on Thursday.

    Following the market opening Thursday, the Dow traded up 0.53% to 40,064.06 while the NASDAQ fell 1.25% to 17,124.88. The S&P 500 also fell, dropping, 0.38% to 5,406.26.

    Check This Out: Jim Cramer: This Tech Stock Is ‘Absolutely Terrific,’ But Jumia? It’s Not Making A Lot Of Money

    Leading and Lagging Sectors

    Real estate shares jumped by 1.4% on Wednesday.

    In trading on Wednesday, information technology shares fell by 2.5%.

    Top Headline

    Honeywell International Inc. (NASDAQ:HON) reported second-quarter results and lowered FY24 EPS guidance.

    Adjusted EPS was $2.49 (+8% Y/Y), beating the consensus of $2.42. Revenue grew 5% Y/Y (organic: +4% Y/Y) to $9.58 billion, beating the consensus of $9.41 billion.

    The company raised sales growth to $39.10 billion-$39.70 billion (from $38.5 billion – $39.3 billion) versus the consensus of $38.76 billion. Honeywell lowered adjusted EPS guidance to $10.05-$10.25 (from $10.15-10.45) versus the estimate of $10.25.

    Equities Trading UP
                           

    • Predictive Oncology Inc. (NASDAQ:POAI) shares shot up 128% to $2.44 after the company entered biomarker discovery market after successful retrospective ovarian cancer study yields compelling results.
    • Shares of Psyence Biomedical Ltd. (NASDAQ:PBM) got a boost, surging 90% to $0.7390 after the company announced the export of nature-derived psilocybin to Australia and said a trial is projected to be initiated shortly following receipt of drug product by trial sites.
    • Salarius Pharmaceuticals, Inc.  (NASDAQ:SLRX) shares were also up, gaining 54% to $3.29.

    Equities Trading DOWN

    • 2U, Inc. (NASDAQ:TWOU) shares dropped 63% to $1.5272. 2U announced a strategic agreement with debtholders to eliminate half of debt and infuse $110 million in new capital.
    • Shares of EZFill Holdings Inc. (NASDAQ:EZFL) were down 38% to $3.84.
    • Kindly MD, Inc. (NASDAQ:KDLY) was down, falling 37% to $2.05 after the company submitted comment to the Department of Justice regarding cannabis rescheduling.

    Also Check This Out: Top 3 Defensive Stocks That Are Ticking Portfolio Bombs

    Commodities

    In commodity news, oil traded down 0.6% to $77.10 while gold traded down 2.2% at $2,362.90.

    Silver traded down 4.9% to $27.87 on Thursday, while copper rose 0.1% to $4.1125.

    Euro zone

    European shares were mostly lower today. The eurozone's STOXX 600 fell 1.1%, Germany's DAX fell 0.9% and France's CAC 40 fell 1.6%. Spain's IBEX 35 Index fell 1%, while London's FTSE 100 rose 0.1%.

    Bank lending to households in the Eurozone rose by 0.3% year-over-year to €6.879 trillion in June. The Ifo Business Climate indicator for Germany fell for a third straight month to a reading of 87 in July from 88.6 in June. The manufacturing climate indicator in France declined to 95.5 in July from 98.9 in the prior month.

    Asia Pacific Markets

    Asian markets closed lower on Thursday, with Japan's Nikkei 225 falling 3.28%, Hong Kong's Hang Seng Index falling 1.77%, China's Shanghai Composite Index declining 0.52% and India's S&P BSE Sensex declining 0.14%.

    Imports to Hong Kong climbed 9% year-over-year to $429.2 billion, while exports from Hong Kong gained 10.7% to $373.5 billion in June. The People's Bank of China cut its one-year policy loan rate.

    Economics

    • U.S. initial jobless claims declined by 10,000 to 235,000 in the week ending July 20, compared to market estimates of 238,000.
    • U.S. durable goods orders fell by 6.6% month-over-month in June.
    • The US economy grew by an annualized 2.8% in the second quarter, up from 1.4% in the prior quarter, and higher than expectations of 2%.

    Now Read This:

    • Wall Street’s Most Accurate Analysts Weigh In On 3 Energy Stocks With Over 6% Dividend Yields
    Get the next $EZFL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EZFL
    $HON
    $KDLY
    $PBM

    CompanyDatePrice TargetRatingAnalyst
    Honeywell International Inc.
    $HON
    1/16/2026$255.00Neutral → Overweight
    Analyst
    Honeywell International Inc.
    $HON
    1/5/2026$220.00Buy → Hold
    Vertical Research
    Honeywell International Inc.
    $HON
    12/15/2025$255.00Outperform
    Evercore ISI
    Honeywell International Inc.
    $HON
    12/3/2025$195.00Neutral
    BNP Paribas Exane
    Honeywell International Inc.
    $HON
    11/18/2025$205.00Buy → Underperform
    BofA Securities
    Honeywell International Inc.
    $HON
    10/27/2025$253.00Sector Perform → Outperform
    RBC Capital Mkts
    Honeywell International Inc.
    $HON
    5/7/2025$250.00Neutral → Buy
    BofA Securities
    Honeywell International Inc.
    $HON
    2/7/2025$236.00 → $260.00Hold → Buy
    Deutsche Bank
    More analyst ratings

    $EZFL
    $HON
    $KDLY
    $PBM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hanish Arnold C bought $3,740 worth of shares (5,000 units at $0.75) (SEC Form 4)

    4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)

    11/24/25 5:08:13 PM ET
    $SLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Exec VP Finance, CFO Rosenblum Mark J bought $16,000 worth of shares (20,000 units at $0.80), increasing direct ownership by 11,299% to 20,177 units (SEC Form 4)

    4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)

    11/20/25 4:42:09 PM ET
    $SLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Farkas Michael D bought $20,985 worth of shares (10,000 units at $2.10), increasing direct ownership by 0.81% to 1,244,731 units (SEC Form 4)

    4 - EzFill Holdings Inc (0001817004) (Issuer)

    6/7/24 4:05:22 PM ET
    $EZFL
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    $EZFL
    $HON
    $KDLY
    $PBM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Kapur Vimal covered exercise/tax liability with 3,575 shares and was granted 8,226 shares, increasing direct ownership by 172% to 7,359 units (SEC Form 4)

    4 - HONEYWELL INTERNATIONAL INC (0000773840) (Issuer)

    2/17/26 4:05:11 PM ET
    $HON
    Aerospace
    Industrials

    Pres & CEO, AERO Technologies Currier James E was granted 3,216 shares and covered exercise/tax liability with 1,346 shares, increasing direct ownership by 53% to 5,377 units (SEC Form 4)

    4 - HONEYWELL INTERNATIONAL INC (0000773840) (Issuer)

    2/17/26 4:04:22 PM ET
    $HON
    Aerospace
    Industrials

    SrVP & Chief HR Officer Mattimore Karen was granted 1,546 shares and covered exercise/tax liability with 675 shares, increasing direct ownership by 4% to 21,595 units (SEC Form 4)

    4 - HONEYWELL INTERNATIONAL INC (0000773840) (Issuer)

    2/17/26 4:03:20 PM ET
    $HON
    Aerospace
    Industrials

    $EZFL
    $HON
    $KDLY
    $PBM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Honeywell upgraded by Analyst with a new price target

    Analyst upgraded Honeywell from Neutral to Overweight and set a new price target of $255.00

    1/16/26 8:20:42 AM ET
    $HON
    Aerospace
    Industrials

    Honeywell downgraded by Vertical Research with a new price target

    Vertical Research downgraded Honeywell from Buy to Hold and set a new price target of $220.00

    1/5/26 9:06:54 AM ET
    $HON
    Aerospace
    Industrials

    Evercore ISI initiated coverage on Honeywell with a new price target

    Evercore ISI initiated coverage of Honeywell with a rating of Outperform and set a new price target of $255.00

    12/15/25 8:32:44 AM ET
    $HON
    Aerospace
    Industrials

    $EZFL
    $HON
    $KDLY
    $PBM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders

    NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced the voting results from its Annual and Special Meeting of Shareholders (the "Meeting"), held at 9:00 a.m. Eastern Time on February 12, 2026. Shareholders voted in favour of all matters of business presented at the Meeting, including the election of directors, the appointment of auditors and the approval of share consolidation authority for the board of directors (the "Board"). All director nominees listed in the Company's management informat

    2/17/26 9:15:00 AM ET
    $PBM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    HONEYWELL FILES ANNUAL REPORT ON FORM 10-K FOR FISCAL YEAR 2025

    CHARLOTTE, N.C., Feb. 17, 2026 /PRNewswire/ -- Honeywell (NASDAQ:HON) today filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission. As previously disclosed in its January 29, 2026 press release announcing fourth quarter and full year 2025 earnings (the "Earnings Release"), Honeywell classified the Productivity Solutions and Services ("PSS") and Warehouse and Workflow Solutions ("WWS") businesses as assets held for sale during the fourth quarter of 2025. The PSS and WWS businesses are planned for sale as

    2/17/26 6:10:00 AM ET
    $HON
    Aerospace
    Industrials

    Psyence BioMed Approves Put Option Agreement with PsyLabs to Secure Strategic Supply and Strengthen Commercialization Pathway

    NEW YORK, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced that its board of directors has ratified the entry into a put option agreement (the "Put Option Agreement") with PsyLabs, a leading developer and manufacturer of pharmaceutical-grade psychedelic compounds. The Put Option Agreement grants PsyLabs the right, but not the obligation, to require the Company to make a further equity investment in PsyLabs by way of a share-for-share exchange at arm's length and at fair market value, subject to the

    2/13/26 6:30:00 PM ET
    $PBM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $EZFL
    $HON
    $KDLY
    $PBM
    SEC Filings

    View All

    Honeywell International Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - HONEYWELL INTERNATIONAL INC (0000773840) (Filer)

    2/17/26 6:12:46 AM ET
    $HON
    Aerospace
    Industrials

    SEC Form 10-K filed by Honeywell International Inc.

    10-K - HONEYWELL INTERNATIONAL INC (0000773840) (Filer)

    2/17/26 6:07:11 AM ET
    $HON
    Aerospace
    Industrials

    SEC Form 6-K filed by Psyence Biomedical Ltd.

    6-K - PSYENCE BIOMEDICAL LTD. (0001985062) (Filer)

    2/13/26 4:01:09 PM ET
    $PBM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $EZFL
    $HON
    $KDLY
    $PBM
    Leadership Updates

    Live Leadership Updates

    View All

    Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders

    NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced the voting results from its Annual and Special Meeting of Shareholders (the "Meeting"), held at 9:00 a.m. Eastern Time on February 12, 2026. Shareholders voted in favour of all matters of business presented at the Meeting, including the election of directors, the appointment of auditors and the approval of share consolidation authority for the board of directors (the "Board"). All director nominees listed in the Company's management informat

    2/17/26 9:15:00 AM ET
    $PBM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Psyence BioMed Achieves Milestone in Natural Ibogaine HCl Production and Strengthens Balance Sheet With No Debt and $12m Cash

    NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced a significant scientific and manufacturing achievement. Through its investment in PsyLabs, Psyence BioMed has become the first Nasdaq-listed company to produce GMP-compliant, high-purity ibogaine hydrochloride (Ibogaine HCl) derived from a naturally extracted, ethically sourced supply in Africa. Ibogaine HCl is the purified, stabilised, crystalline salt form of ibogaine used in clinical and therapeutic settings and represents the standard ph

    1/5/26 9:15:00 AM ET
    $PBM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    HONEYWELL APPOINTS INDRA NOOYI TO BOARD OF DIRECTORS

    CHARLOTTE, N.C., Dec. 10, 2025 /PRNewswire/ -- Honeywell (NASDAQ:HON) announced today that its Board of Directors has appointed Indra Nooyi, 70, former Chair and Chief Executive Officer of PepsiCo, to its Board of Directors as an Independent Director, effective January 1, 2026. Nooyi served as Chief Executive Officer of PepsiCo from 2006 through 2018 and Chair of its board of directors from 2007 to 2019. Prior to that, she spent five years as President and Chief Financial Officer and was a member of the PepsiCo board of directors. During her tenure at PepsiCo, Nooyi was the chief architect of Performance with Purpose, PepsiCo's pledge to deliver sustained growth by making more nutritious pr

    12/10/25 7:00:00 AM ET
    $HON
    Aerospace
    Industrials

    $EZFL
    $HON
    $KDLY
    $PBM
    Financials

    Live finance-specific insights

    View All

    HONEYWELL ANNOUNCES QUARTERLY DIVIDEND

    CHARLOTTE, N.C., Feb. 13, 2026 /PRNewswire/ -- Honeywell (NASDAQ:HON) today announced that its Board of Directors has declared a quarterly dividend payment of $1.19 per share on the Company's common stock. The dividend is payable on March 13, 2026, out of surplus to holders of record at the close of business on February 27, 2026. About HoneywellHoneywell is an integrated operating company serving a broad range of industries and geographies around the world, with a portfolio that is underpinned by our Honeywell Accelerator operating system and Honeywell Forge platform. As a tru

    2/13/26 4:15:00 PM ET
    $HON
    Aerospace
    Industrials

    HONEYWELL REPORTS FOURTH QUARTER 2025 RESULTS, WITH ADJUSTED SALES AND ADJUSTED EARNINGS ABOVE HIGH END OF GUIDANCE; ISSUES 2026 OUTLOOK

    Fourth Quarter Sales of $9.8 Billion, Up 6%, Adjusted Sales1 of $10.1 Billion, Up 10%, Up 11% Organic1Fourth Quarter GAAP Earnings Per Share (EPS) of $0.49 and Adjusted EPS1 of $2.59Fourth Quarter Orders Up 23% Organically, Driving Backlog to Over $37 BillionExpect 2026 Adjusted EPS2,3 of $10.35 - $10.65, Up 6% - 9%Honeywell Aerospace Spin-Off Now Expected in Third Quarter 2026; Leadership Team AnnouncedCHARLOTTE, N.C., Jan. 29, 2026 /PRNewswire/ -- Honeywell (NASDAQ:HON) today announced results for the fourth quarter and full year 2025 and issued its outlook for 2026. The company also provided an update on anticipated timing for the spin-off of Honeywell Aerospace into an independent public

    1/29/26 6:00:00 AM ET
    $HON
    Aerospace
    Industrials

    HONEYWELL TO RELEASE FOURTH QUARTER FINANCIAL RESULTS AND ANNOUNCE 2026 OUTLOOK DURING ITS INVESTOR CONFERENCE CALL ON THURSDAY, JANUARY 29

    CHARLOTTE, N.C., Jan. 2, 2026 /PRNewswire/ -- Honeywell (NASDAQ:HON) will issue its fourth quarter financial results and 2026 outlook before the opening of the Nasdaq Stock Market on Thursday, January 29. The company will also hold a conference call at 8:30 a.m. EST. Presentation Materials / Webcast Details A real-time audio webcast of the presentation can be accessed at http://www.honeywell.com/investor, where related materials will be posted prior to the presentation and a replay of the webcast will be available for 30 days following the presentation. Honeywell is an integr

    1/2/26 8:30:00 AM ET
    $HON
    Aerospace
    Industrials

    $EZFL
    $HON
    $KDLY
    $PBM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Psyence Biomedical Ltd.

    SC 13G - PSYENCE BIOMEDICAL LTD. (0001985062) (Subject)

    12/13/24 9:16:01 AM ET
    $PBM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Psyence Biomedical Ltd.

    SC 13G/A - PSYENCE BIOMEDICAL LTD. (0001985062) (Subject)

    12/9/24 1:36:43 PM ET
    $PBM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Psyence Biomedical Ltd.

    SC 13G/A - PSYENCE BIOMEDICAL LTD. (0001985062) (Subject)

    12/4/24 4:38:27 PM ET
    $PBM
    Biotechnology: Pharmaceutical Preparations
    Health Care